EP Patent

EP3280448A1 — Abiraterone acetate lipid formulations

Assigned to Capsugel Belgium NV · Expires 2018-02-14 · 8y expired

What this patent protects

Abiraterone acetate lipid formulations.

USPTO Abstract

Abiraterone acetate lipid formulations.

Drugs covered by this patent

Patent Metadata

Patent number
EP3280448A1
Jurisdiction
EP
Classification
—
Expires
2018-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Capsugel Belgium NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.